Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Gastroenterology | Immunology | Family Medicine
Disease Category: Ulcerative Colitis
Location: United States, VA
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of XXXXXXXXX Induction Therapy, Administered Subcutaneously, in Subjects with Moderately to Severely Active Ulcerative Colitis.
Patient Inclusion Criteria:
Patient Exclusion Criteria:
Date Last Changed:
July 24, 2013
Michelle Spady, Research ManagerGastroenterology Associates of Tidewater112 Gainsborough Square, Suite 200Chesapeake, VA 23320Phone: 757-547-0798 ext. 1134Fax: 757-410-4123
Research Center Information: Gastroenterology Associates of Tidewater
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2015 CenterWatch.